SCHEMBL287773

SCHEMBL287773

CS(=O)(=O)NNC(=O)C1=CN(CC(=O)c2cccs2)C=CC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
GAA P10253 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 2/20 0.36
HTT P42858 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
ALOX15 P16050 1/20 0.35
PARG Q86W56 1/20 0.35
HPGD P15428 1/20 0.34
ERCC5 P28715 1/20 0.34
FEN1 P39748 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661687 0.89 ERCC5 (0.43) ALDH1A1GAATSHRHTTMEN1
SCHEMBL662303 0.89 ALDH1A1 (0.38) ALDH1A1GAASMN1; SMN2TSHRHTT
SCHEMBL7799733 0.87 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2TSHRHTTMEN1
SCHEMBL660109 0.87 CTNNB1 (0.36) ALDH1A1GAASMN1; SMN2TSHRHTT
SCHEMBL660129 0.87 GAA (0.46) ALDH1A1GAAMEN1KMT2ALMNA
SCHEMBL660111 0.87 RAB9A (0.46) ALDH1A1GAASMN1; SMN2MEN1KMT2A
SCHEMBL287088 0.86 GAA (0.46) ALDH1A1GAASMN1; SMN2HTTMEN1
SCHEMBL27871718 0.85 ERCC5 (0.43) ALDH1A1GAATSHRHTTMEN1
SCHEMBL658335 0.84 ALDH1A1 (0.61) ALDH1A1GAASMN1; SMN2HTTMEN1
SCHEMBL286776 0.84 ALDH1A1 (0.44) ALDH1A1GAASMN1; SMN2TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
EP-2427432-A2 NOVEL HETEROCYCLIC COMPOUNDS Torrent Pharmaceuticals Limited (IN) 2012-03-14 EP disclosed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed
WO-2010128528-A2 NOVEL HETEROCYCLIC COMPOUNDS TORRENT PHARMACEUTICALS LIMITED (IN) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT ALDH1A1 676/4885GAA 194/4885SMN1; SMN2 640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.